Keryx Biopharmaceuticals, Inc. (KERX) Tops Q4 EPS by 2c
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Price: $8.13 +1.12%
EPS Growth %: +76.9%
Financial Fact:
Total operating expenses: 9.16M
Today's EPS Names:
RAVN, CAMT, HAST, More
EPS Growth %: +76.9%
Financial Fact:
Total operating expenses: 9.16M
Today's EPS Names:
RAVN, CAMT, HAST, More
Trade KERX Now!
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- China Xiniya Fashion (XNY) Q1 Profit Slips to RMB0.009/ADS
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
